Participating Faculty

Current Treatment Options for Osteoarthritis

This supplement to The American Journal of Managed Care reviews the economic and clinical implications of osteoarthritis, as well as current treatment options.

Participating Faculty

Roy Davis Altman, MD

Professor of Medicine

Division of Rheumatology and Immunology

David Geffen School of Medicine

University of California Los Angeles

Los Angeles, California

Ryan Bitton, PharmD, MBA

Manager, Pharmacy Services

Health Plan of Nevada, Inc.

Las Vegas, Nevada

Roland W. Moskowitz, MD

Clinical Professor

Department of Medicine

Case Western Reserve University

Cleveland, Ohio

Faculty Disclosures

Roy Davis Altman, MD

Consultant:

Endo

Ferring

Novartis

Research Grants:

Ferring

Novartis

Lecturer:

Ferring

Forest

Ryan Bitton, PharmD, MBA

Roland W. Moskowitz, MD

, and , have nothing to disclose.

Funding

Endo Pharmaceuticals.

This supplement has been supported by funding from

The contents of this supplement may include information regarding the use of products that may be inconsistent with or outside the approved labeling for these products in the United States. Physicians should note that the use of these products outside current approved labeling is considered experimental and are advised to consult prescribing information for these products.

Download PDF: Participating Faculty